Skip to main content
. 2016 Apr 2;15:56. doi: 10.1186/s12933-016-0365-x

Fig. 3.

Fig. 3

End stage renal disease free rates stratified by chronic kidney disease or not for ACEi and ARB users after propensity score weighting. ACEi angiotensin converting enzyme inhibitors, ARB angiotensin receptor blockers, ESRD end stage renal disease, CKD chronic kidney disease